Neurodevelopmental, emotional, and behavioural problems in Duchenne muscular dystrophy in relation to underlying dystrophin gene mutations

Developmental Medicine and Child Neurology

Volumn 58, Issue 1, 2016, Pages 77-84

  Ricotti, Valeria ^a   Mandy, William P L ^a   Scoto, Mariacristina ^a   Pane, Marika ^b   Deconinck, Nicolas ^c,d   Messina, Sonia ^e   Mercuri, Eugenio ^a,b   Skuse, David H ^a   Muntoni, Francesco ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b CATHOLIC UNIVERSITY   (Italy)

^c GHENT UNIVERSITY HOSPITAL   (Belgium)

^d HOP UNIV DES ENFANTS REINE FABIOLA   (Belgium)

^e UNIVERSITY OF MESSINA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

DYSTROPHIN; ISOPROTEIN; DMD PROTEIN, HUMAN;

ADOLESCENT; ARTICLE; AUTISM; CHILD; DUCHENNE MUSCULAR DYSTROPHY; EMOTIONAL DISORDER; EXON; GENE MUTATION; HUMAN; HYPERACTIVITY; INTELLECTUAL IMPAIRMENT; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; MULTICENTER STUDY; PARENT; PRIORITY JOURNAL; PROBLEM BEHAVIOR; QUESTIONNAIRE; STRUCTURED INTERVIEW; ATTENTION DEFICIT AND DISRUPTIVE BEHAVIOR DISORDERS; AUTISM SPECTRUM DISORDER; CLINICAL TRIAL; COMPLICATION; GENETICS; INTELLECTUAL DISABILITY; PATHOPHYSIOLOGY; PRESCHOOL CHILD;

ADOLESCENT; ATTENTION DEFICIT AND DISRUPTIVE BEHAVIOR DISORDERS; AUTISM SPECTRUM DISORDER; CHILD; CHILD, PRESCHOOL; DYSTROPHIN; HUMANS; INTELLECTUAL DISABILITY; MALE; MUSCULAR DYSTROPHY, DUCHENNE; PROBLEM BEHAVIOR;

EID: 84955186895     PISSN: 00121622     EISSN: 14698749     Source Type: Journal    
DOI: 10.1111/dmcn.12922     Document Type: Article

References (38)

1. Bushby K, Finkel R, Birnkrant DJ, et al. Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management. Lancet Neurol 2010; 9: 77-93.
2. Pane M, Scalise R, Berardinelli A, et al. Early neurodevelopmental assessment in Duchenne muscular dystrophy. Neuromuscul Disord 2013; 23: 451-5.
3. Muntoni F, Torelli S, Ferlini A. Dystrophin and mutations: one gene, several proteins, multiple phenotypes. Lancet Neurol 2003; 2: 731-40.
4. Felisari G, Martinelli Boneschi F, Bardoni A, et al. Loss of Dp140 dystrophin isoform and intellectual impairment in Duchenne dystrophy. Neurology 2000; 55: 559-64.
5. Daoud F, Angeard N, Demerre B, et al. Analysis of Dp71 contribution in the severity of mental retardation through comparison of Duchenne and Becker patients differing by mutation consequences on Dp71 expression. Hum Mol Genet 2009; 18: 3779-94.
6. Lorusso ML, Civati F, Molteni M, Turconi AC, Bresolin N, D'Angelo MG. Specific profiles of neurocognitive and reading functions in a sample of 42 Italian boys with Duchenne muscular dystrophy. Child Neuropsychol 2013; 19: 350-69.
7. Hinton VJ, Cyrulnik SE, Fee RJ, et al. Association of autistic spectrum disorders with dystrophinopathies. Pediatr Neurol 2009; 41: 339-46.
8. Pane M, Lombardo ME, Alfieri P, et al. Attention deficit hyperactivity disorder and cognitive function in Duchenne muscular dystrophy: phenotype-genotype correlation. J Pediatr 2012; 161: 705-9.
9. Hendriksen JG, Vles JS. Neuropsychiatric disorders in males with duchenne muscular dystrophy: frequency rate of attention-deficit hyperactivity disorder (ADHD), autism spectrum disorder, and obsessive-compulsive disorder. J Child Neurol 2008; 23: 477-81.
10. Skuse DH, Mandy WP, Scourfield J. Measuring autistic traits: heritability, reliability and validity of the Social and Communication Disorders Checklist. Br J Psychiatry 2005; 187: 568-72.
11. Skuse DH, Mandy W, Steer C, et al. Social communication competence and functional adaptation in a general population of children: preliminary evidence for sex-by-verbal IQ differential risk. J Am Acad Child Adolesc Psychiatry 2009; 48: 128-37.
12. Wechsler D. Weschler Intelligence Scale for Children - Fourth Edition (WISC-IV). London: Pearson Assessment, 2004.
13. Raiford SE, Weiss LG, Rolfhus E, Coalson D. WISC-IV General Ability Index (WISC-IV Technical Report No. 4). 2005. Available from: http://images.pearsonclinical.com/images/assets/WISC-IV/80720_WISCIV_Hr_r4.pdf (accessed 1 October 2011)
14. ™. London, UK: Pearson, 2004.
15. Raven J. Raven's Coloured Progressive Matrices. London, UK: Pearson, 2008.
16. Strauss E, Sherman EMS, Spreen O. A Compendium of Neuropsychological Tests: Administration, Norms, and Commentary. New York, NY: Oxford University Press, 2006.
17. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders: DSM-IV-TR. Washington, DC: American Psychiatric Association, 2000.
18. Santosh PJ, Mandy WP, Puura K, Kaartinen M, Warrington R, Skuse DH. The construction and validation of a short form of the developmental, diagnostic and dimensional interview. Eur Child Adolesc Psychiatry 2009; 18: 521-4.
19. Conners CK, Sitarenios G, Parker JD, Epstein JN. The revised Conners' Parent Rating Scale (CPRS-R): factor structure, reliability, and criterion validity. J Abnorm Child Psychol 1998; 26: 257-68.
20. Achenbach T. Manual for the Child Behavior Checklist/4 - 18 and 1991 Profile. Burlington, VT: University of Vermont Department of Psychiatry, 1991.
21. Skuse D, Lawrence K, Tang J. Measuring social-cognitive functions in children with somatotropic axis dysfunction. Horm Res 2005; 64(Suppl. 3): 73-82.
22. Fee RJ, Hinton VJ. Resilience in children diagnosed with a chronic neuromuscular disorder. J Dev Behav Pediatr 2011; 32: 644-50.
23. Cotton S, Voudouris NJ, Greenwood KM. Intelligence and Duchenne muscular dystrophy: full-scale, verbal, and performance intelligence quotients. Dev Med Child Neurol 2001; 43: 497-501.
24. Hinton VJ, De Vivo DC, Nereo NE, Goldstein E, Stern Y. Selective deficits in verbal working memory associated with a known genetic etiology: the neuropsychological profile of duchenne muscular dystrophy. J Int Neuropsychol Soc 2001; 7: 45-54.
25. Simonoff E, Pickles A, Charman T, Chandler S, Loucas T, Baird G. Psychiatric disorders in children with autism spectrum disorders: prevalence, comorbidity, and associated factors in a population-derived sample. J Am Acad Child Adolesc Psychiatry 2008; 47: 921-9.
26. Taylor B, Jick H, Maclaughlin D. Prevalence and incidence rates of autism in the UK: time trend from 2004-2010 in children aged 8 years. BMJ Open 2013; 3: e003219.
27. Polanczyk G, de Lima MS, Horta BL, Biederman J, Rohde LA. The worldwide prevalence of ADHD: a systematic review and metaregression analysis. Am J Psychiatry 2007; 164: 942-8.
28. Hiscock H, Bayer JK, Lycett K, et al. Preventing mental health problems in children: the Families in Mind population-based cluster randomised controlled trial. BMC Public Health 2012; 12: 420.
29. Hendriksen JG, Poysky JT, Schrans DG, Schouten EG, Aldenkamp AP, Vles JS. Psychosocial adjustment in males with Duchenne muscular dystrophy: psychometric properties and clinical utility of a parent-report questionnaire. J Pediatr Psychol 2009; 34: 69-78.
30. Darke J, Bushby K, Le Couteur A, McConachie H. Survey of behaviour problems in children with neuromuscular diseases. Eur J Paediatr Neurol 2006; 10: 129-34.
31. Taylor PJ, Betts GA, Maroulis S, et al. Dystrophin gene mutation location and the risk of cognitive impairment in Duchenne muscular dystrophy. PLoS ONE 2010; 5: e8803.
32. Sekiguchi M, Zushida K, Yoshida M, et al. A deficit of brain dystrophin impairs specific amygdala GABAergic transmission and enhances defensive behaviour in mice. Brain 2009; 132: 124-35.
33. Nicchia GP, Rossi A, Nudel U, Svelto M, Frigeri A. Dystrophin-dependent and -independent AQP4 pools are expressed in the mouse brain. Glia 2008; 56: 869-76.
34. Haenggi T, Soontornmalai A, Schaub MC, Fritschy JM. The role of utrophin and Dp71 for assembly of different dystrophin-associated protein complexes (DPCs) in the choroid plexus and microvasculature of the brain. Neuroscience 2004; 129: 403-13.
35. Doorenweerd N, Straathof CS, Dumas EM, et al. Reduced cerebral gray matter and altered white matter in boys with Duchenne muscular dystrophy. Ann Neurol 2014; 76: 403-11.
36. Tracey I, Scott RB, Thompson CH, et al. Brain abnormalities in Duchenne muscular dystrophy: phosphorus-31 magnetic resonance spectroscopy and neuropsychological study. Lancet 1995; 345: 1260-4.
37. Goodnough CL, Gao Y, Li X, et al. Lack of dystrophin results in abnormal cerebral diffusion and perfusion in vivo. NeuroImage 2014; 102P2: 809-16.
38. Goyenvalle A, Griffith G, Babbs A, et al. Functional correction in mouse models of muscular dystrophy using exon-skipping tricyclo-DNA oligomers. Nat Med 2015; 21: 270-5.